Hasan Abbas Zaheer: How the Future of Thalassaemia Management Can be Made More Equitable and Sustainable
Hasan Abbas Zaheer, Member of National Technical Advisory Committee, M/o National Health Services, Advisor at World Health Organization, shared a post on LinkedIn:
“I am delighted to share that our Review article, ‘Future-Proofing Thalassemia Care: Harnessing Scalable Therapies, Artificial Intelligence, and Global Collaboration,’ has been accepted for publication in The Lancet Hematology, one of the world’s most prestigious medical journals.
It has been a privilege to contribute as a co-author alongside an outstanding international team of experts in thalassemia care.
The Review examines how the future of thalassaemia management can be made more equitable and sustainable by exploring scalable, affordable, and innovative solutions.
It highlights the potential of repurposed therapies such as hydroxyurea and thalidomide, strategies to expand access to gene therapies, the transformative role of artificial intelligence in diagnosis and patient care, and the importance of global collaboration, multidisciplinary training, and research networks in improving outcomes particularly for patients living in low- and middle-income countries, where the greatest burden of disease exists.
Hopefully this work will contribute to ongoing efforts to make high-quality thalassemia care accessible to all, regardless of where patients live.
My sincere thanks and congratulations to all my co-authors for this remarkable collaborative achievement.”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research